Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
30.96
-1.06 (-3.30%)
Dec 3, 2024, 2:19 PM EST - Market open
Akero Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 316.07 | 234.21 | 249.77 | 150.48 | 187.24 | 64.79 | Upgrade
|
| Short-Term Investments | 401.18 | 315.8 | 101.68 | 37.78 | 81.15 | 71.61 | Upgrade
|
| Cash & Short-Term Investments | 717.25 | 550.01 | 351.45 | 188.26 | 268.39 | 136.4 | Upgrade
|
| Cash Growth | 29.30% | 56.50% | 86.68% | -29.86% | 96.76% | 79.53% | Upgrade
|
| Prepaid Expenses | 29.64 | 9.95 | 3.72 | 5.32 | 2.96 | 1.65 | Upgrade
|
| Total Current Assets | 746.89 | 559.96 | 355.17 | 193.58 | 271.35 | 138.05 | Upgrade
|
| Property, Plant & Equipment | 0.84 | 1.03 | 1.29 | 1.55 | 1.79 | - | Upgrade
|
| Long-Term Investments | 69.82 | 19.28 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | 0.11 | 0.42 | 0.2 | 0.07 | Upgrade
|
| Total Assets | 817.55 | 580.27 | 356.57 | 195.55 | 273.34 | 138.12 | Upgrade
|
| Accounts Payable | 25.22 | 7.04 | 7.97 | 6.71 | 3.43 | 0.95 | Upgrade
|
| Accrued Expenses | 17.44 | 11.57 | 10.79 | 18.22 | 9.39 | 8.34 | Upgrade
|
| Current Portion of Leases | 0.28 | 0.26 | 0.33 | 0.21 | 0.29 | 0.09 | Upgrade
|
| Other Current Liabilities | 0.35 | 0.26 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 43.29 | 19.13 | 19.08 | 25.13 | 13.11 | 9.37 | Upgrade
|
| Long-Term Debt | 35.12 | 24.96 | 9.54 | - | - | - | Upgrade
|
| Long-Term Leases | 0.61 | 0.82 | 1.08 | 1.31 | 1.52 | - | Upgrade
|
| Other Long-Term Liabilities | 0.2 | 0.05 | 0.31 | - | - | 0.02 | Upgrade
|
| Total Liabilities | 79.22 | 44.97 | 30.01 | 26.44 | 14.63 | 9.39 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,492 | 1,109 | 748.86 | 479.44 | 468.24 | 259.05 | Upgrade
|
| Retained Earnings | -756.13 | -574.1 | -422.34 | -310.3 | -209.53 | -130.32 | Upgrade
|
| Comprehensive Income & Other | 2.1 | 0.27 | 0.04 | -0.03 | -0 | -0.01 | Upgrade
|
| Total Common Equity | 738.33 | 535.31 | 326.56 | 169.11 | 258.71 | 128.73 | Upgrade
|
| Shareholders' Equity | 738.33 | 535.31 | 326.56 | 169.11 | 258.71 | 128.73 | Upgrade
|
| Total Liabilities & Equity | 817.55 | 580.27 | 356.57 | 195.55 | 273.34 | 138.12 | Upgrade
|
| Total Debt | 36.01 | 26.04 | 10.95 | 1.52 | 1.81 | 0.09 | Upgrade
|
| Net Cash (Debt) | 751.06 | 543.25 | 340.5 | 186.74 | 266.58 | 136.32 | Upgrade
|
| Net Cash Growth | 27.95% | 59.54% | 82.34% | -29.95% | 95.56% | 79.42% | Upgrade
|
| Net Cash Per Share | 11.84 | 10.33 | 8.73 | 5.36 | 8.47 | 9.05 | Upgrade
|
| Filing Date Shares Outstanding | 69.8 | 56.3 | 46.97 | 35.01 | 34.77 | 28.61 | Upgrade
|
| Total Common Shares Outstanding | 69.61 | 55.75 | 46.87 | 34.9 | 34.74 | 28.57 | Upgrade
|
| Working Capital | 703.6 | 540.83 | 336.09 | 168.45 | 258.23 | 128.68 | Upgrade
|
| Book Value Per Share | 10.61 | 9.60 | 6.97 | 4.85 | 7.45 | 4.51 | Upgrade
|
| Tangible Book Value | 738.33 | 535.31 | 326.56 | 169.11 | 258.71 | 128.73 | Upgrade
|
| Tangible Book Value Per Share | 10.61 | 9.60 | 6.97 | 4.85 | 7.45 | 4.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.